After two years of virtual Masterclasses, Myeloma Patients Europe (MPE) held our Masterclass 2022 in Amsterdam, The Netherlands, between 1 and 3 July 2022. Sessions covered the most relevant topics for patient organisations on treatment, access and quality of life. Each speaker summarised their talks, explaining the most important points covered in each session. Watch the videos in the gallery below.
We also celebrated our 10th anniversary, which had to be cancelled last year due to the covid pandemic. Have a look at the pictures of the MPE Masterclass below!
The MPE Masterclass 2021 was held virtually and included lectures on myeloma and AL amyloidosis diagnosis and treatment, discussions on access challenges across Europe, presentations on the impact of COVID-19 on the patient community, and workshops to support the capacity of patient organisations.
Watch below the recordings of the presentations given on the 2nd and 3rd July 2021.
«
Prev
1
/
1
Next
»
MPE Masterclass 2021 | Welcome message
MPE Masterclass - A welcome message from Dr María Victoria Mateos
MPE Masterclass - A welcome message from Dr Mohamad Mohty
MPE Masterclass 2021 | The early detection and diagnosis of MGUS and SMM
MPE Masterclass 2021 | Immunotherapy in the treatment of myeloma and AL amyloidosis
Masterclass 2021 | COVID 19 and the effect on the treatment for myeloma and AL amyloidosis patients
MPE Masterclass 2021 | New developments and controversies in the myeloma treatment pathway
MPE Masterclass 2021 |Developments in AL amyloidosis diagnostic centres of expertise
MPE Masterclass 2021 | Palliative Care and quality of life
MPE Masterclass 2021 | MPE members response to and resiliency during COVID 19. Poland
MPE Masterclass 2021 | MPE members response to and resiliency during COVID 19. Israel
MPE Masterclass 2021 | Panel discussion on Minimal Residual Disease (MRD). Hans Scheurer
MPE Masterclass 2021 | Panel discussion on Minimal Residual Disease (MRD). Hans Jacobs
MPE Masterclass 2021 | Panel discussion on Minimal Residual Disease (MRD). Paula van Hennik
MPE Masterclass 2021 | Access to new treatments in CEE countries
MPE Masterclass 2021 | Myeloma related diseases
MPE Masterclass 2021 | Fundraising for patient groups and collaboration with industry
«
Prev
1
/
1
Next
»
Annual Masterclass 2020
The MPE Annual General Meeting (AGM) 2020 was cancelled due to the COVID-19 outbreak. The educational programme planned to be held in the Annual Masterclass was replaced by the MPE Webinars series.
«
Prev
1
/
1
Next
»
MPE AGM 2020 - Webinar on Myeloma and AL amyloidosis treatment updates
MPE AGM 2020 - Webinar on reimbursement and Health Technology Assessment (HTA) in Europe
MPE AGM2020 webinar series - Big data, the Harmony example
Watch the webinar on personalised medicines in myeloma and AL amyloidosis
Minimal Residual Disease (MRD) in myeloma and related diseases
Webinar on the impact of myeloma and AL amyloidosis in carers
«
Prev
1
/
1
Next
»
Annual Masterclass 2019
«
Prev
1
/
1
Next
»
MPE AGM 2019 outtakes
Myeloma Treatment Updates
Surrogate end-points in myeloma and AL amyloidosis
Measuring and utilising quality of life
AL Amyloidosis
The role of CAR-T
«
Prev
1
/
1
Next
»
Annual Masterclass 2018
«
Prev
1
/
1
Next
»
MPE Capacity Building Programme
Community Advisory Boards and case studies of MPE member groups
Rehabilitation, self-care and quality of life
Journey to a professional and empowered advocate
Clinical trials design and study endpoints
Myeloma related diseases
Drug access and affordability
Coping with a chronic disease
Update on diagnosis and treatment of AL amyloidosis
«
Prev
1
/
1
Next
»
Annual Masterclass 2017
«
Prev
1
/
1
Next
»
MPE dialogues - “Where are we now in myeloma and how does the future look like?”
Welcome, introductions and driving throught the conference
The European Atlas of Access to Myeloma Treatment
Update on current diagnosis and treatment of myeloma and related diseases
Clinical trials and drugs under development in myeloma and AL Amyloidosis
Treatment of myeloma in the light of access barriers
Patient advocate development strategies: how can an umbrella organisation help you
«
Prev
1
/
1
Next
»
Annual Masterclass 2016
«
Prev
1
/
1
Next
»
Treating myeloma. An update on the current myeloma treatment guidelines
Myeloma and Amyloidosis 101
What is multiple myeloma associated amyloidosis?
Advocacy session 1 – Patient involvement in clinical research
Welcome and introductions
The MPE Atlas: myeloma UK case study
Evidence based advocacy: implementing the MPE Atlas
Atlas Coaching Programme
Myeloma beyond C.R.A.B. An update on the current mueloma diagnosis guidelines
